• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Eugia Pharma`s Generic Neostigmine Methylsulfate Receives Approval in the U.S.

    FDA

    Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection)

    PR NEWSWIRE

    Avet`s Generic Neostigmine Methylsulfate Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of August 24, 2022

    FDA

    Hikma`s Generic Neostigmine Methylsulfate Receives Approval in the U.S.

    FDA

    Dr. Reddy Generic Neostigmine Methylsulfate Receives Approval in US

    FDA

    Enforcement Report - Week of June 8, 2022

    FDA

    Enforcement Report - Week of February 2, 2022

    FDA

    Indoco`s Generic Neostigmine Methylsulfate Receives Approval in the US

    FDA

    Gland Pharma Ltd`s Generic Neostigmine Methylsulfate Receives Approval in the US

    FDA

    KRS Global Biotechnology Issues Voluntary Nationwide Recall of All Human and Animal Sterile Drug Products

    FDA

    Enforcement Report - Week of August 14, 2019

    FDA

    Premier Pharmacy Labs Issues Voluntary Nationwide Recall of all Unexpired Sterile Drug Product Lots Due to Lack of Sterility Assurance

    FDA

    Be Pharms Generic Neostigmine Methylsulfate Receives Approval in US

    FDA

    Renaissance`s Generic Neostigmine Methylsulfate Receives Approval in US

    FDA

    Dr Reddys Labs Ltd’s Generic Neostigmine Methylsulfate Receives Approval in the US

    FDA

    Enforcement Report - Week of July 11, 2018

    FDA

    Fagron Sterile Services Issues Voluntary Recall of Neostigmine Methylsulfate Due to Mislabeling

    FDA

    Fagron Issues Voluntary Nationwide Recall of Neostigmine Methylsulfate

    FDA

    Amneal Pharms Generic Neostigmine Methylsulfate Receives Approval In US

    FDA

    Luitpold Pharms Generic Neostigmine Methylsulfate Receives Approval In US

    FDA

    Enforcement Report - Week of May 2, 2018

    FDA

    Premier Pharmacy Issues Voluntary Nationwide Recall of Specific Sterile Injectable Products Lots

    FDA

    Enforcement Report - Week of February 28, 2018

    FDA

    Enforcement Report - Week of December 27, 2017

    FDA

    Amphastar Pharm’s Generic Neostigmine Methylsulfate Receives Approval In US

    FDA

    Enforcement Report - Week of August 16, 2017

    FDA

    Par Sterile Products Generics Neostigmine Methylsulfate Receives Approval In US

    FDA

    These 10 Drugs Are Busting Hospital Budgets

    FORBES

    Reducing The Number Of Unapproved Drugs While Working To Prevent Drug Shortages: A Job That Calls For Strong Collaboration In FDA

    FDA VOICE

    Fresenius Kabi AG Receives FDA Approval For Neostigmine Methylsulfate Injection

    BIOSPACE

    Hikma launches neostigmine methylsulfate injection in US market

    PHARMABIZ

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.